ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Treatment Drugs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-4I9425
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Treatment Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cancer Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-4I9425
Report
January 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Novartis
Bristol–Myers Squibb
Amgen Inc
Johnson & Johnson
Pfizer Inc
Takeda
Eli Lilly
Astrazeneca plc
Astellas
Merck
Sanofi
Bayer
Biogen Idec
Eisai Co Ltd
TEVA
Otsuka
Merck KGaA
Ipsen S A
AbbVie
Gilead Sciences
Celgene

Cancer Treatment Drugs Market Size

The global market for Cancer Treatment Drugs was valued at US$ 211480 million in the year 2024 and is projected to reach a revised size of US$ 378570 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Cancer Treatment Drugs Market

Cancer Treatment Drugs Market

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cancer Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Treatment Drugs.
The Cancer Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cancer Treatment Drugs Market Report

Report Metric Details
Report Name Cancer Treatment Drugs Market
Accounted market size in year US$ 211480 million
Forecasted market size in 2031 US$ 378570 million
CAGR 8.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy (Biologic Therapy)
  • Others
Segment by Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka, Merck KGaA, Ipsen, AbbVie, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cancer Treatment Drugs Market growing?

Ans: The Cancer Treatment Drugs Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Cancer Treatment Drugs Market size in 2031?

Ans: The Cancer Treatment Drugs Market size in 2031 will be US$ 378570 million.

What is the Cancer Treatment Drugs Market share by type?

Ans: In terms of product, Chemotherapy is the largest segment, with a share about 50%.

Who are the main players in the Cancer Treatment Drugs Market report?

Ans: The main players in the Cancer Treatment Drugs Market are Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co., Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka, Merck KGaA, Ipsen, AbbVie, Gilead Sciences

What are the Application segmentation covered in the Cancer Treatment Drugs Market report?

Ans: The Applications covered in the Cancer Treatment Drugs Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory or Lung Cancer, Others

What are the Type segmentation covered in the Cancer Treatment Drugs Market report?

Ans: The Types covered in the Cancer Treatment Drugs Market report are Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy (Biologic Therapy), Others

1 Cancer Treatment Drugs Market Overview
1.1 Product Definition
1.2 Cancer Treatment Drugs by Type
1.2.1 Global Cancer Treatment Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Cancer Treatment Drugs by Application
1.3.1 Global Cancer Treatment Drugs Market Value by Application (2024 VS 2031)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Global Cancer Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Cancer Treatment Drugs Revenue 2020-2031
1.4.2 Global Cancer Treatment Drugs Sales 2020-2031
1.4.3 Global Cancer Treatment Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cancer Treatment Drugs Market Competition by Manufacturers
2.1 Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cancer Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cancer Treatment Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cancer Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Treatment Drugs, Product Type & Application
2.7 Global Key Manufacturers of Cancer Treatment Drugs, Date of Enter into This Industry
2.8 Global Cancer Treatment Drugs Market Competitive Situation and Trends
2.8.1 Global Cancer Treatment Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cancer Treatment Drugs Players Market Share by Revenue
2.8.3 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cancer Treatment Drugs Market Scenario by Region
3.1 Global Cancer Treatment Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cancer Treatment Drugs Sales by Region: 2020-2031
3.2.1 Global Cancer Treatment Drugs Sales by Region: 2020-2025
3.2.2 Global Cancer Treatment Drugs Sales by Region: 2026-2031
3.3 Global Cancer Treatment Drugs Revenue by Region: 2020-2031
3.3.1 Global Cancer Treatment Drugs Revenue by Region: 2020-2025
3.3.2 Global Cancer Treatment Drugs Revenue by Region: 2026-2031
3.4 North America Cancer Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cancer Treatment Drugs Sales by Country (2020-2031)
3.4.3 North America Cancer Treatment Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cancer Treatment Drugs Sales by Country (2020-2031)
3.5.3 Europe Cancer Treatment Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Treatment Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Cancer Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cancer Treatment Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Cancer Treatment Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cancer Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cancer Treatment Drugs Sales by Country (2020-2031)
3.7.3 Latin America Cancer Treatment Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cancer Treatment Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cancer Treatment Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cancer Treatment Drugs Sales by Type (2020-2031)
4.1.1 Global Cancer Treatment Drugs Sales by Type (2020-2025)
4.1.2 Global Cancer Treatment Drugs Sales by Type (2026-2031)
4.1.3 Global Cancer Treatment Drugs Sales Market Share by Type (2020-2031)
4.2 Global Cancer Treatment Drugs Revenue by Type (2020-2031)
4.2.1 Global Cancer Treatment Drugs Revenue by Type (2020-2025)
4.2.2 Global Cancer Treatment Drugs Revenue by Type (2026-2031)
4.2.3 Global Cancer Treatment Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Cancer Treatment Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cancer Treatment Drugs Sales by Application (2020-2031)
5.1.1 Global Cancer Treatment Drugs Sales by Application (2020-2025)
5.1.2 Global Cancer Treatment Drugs Sales by Application (2026-2031)
5.1.3 Global Cancer Treatment Drugs Sales Market Share by Application (2020-2031)
5.2 Global Cancer Treatment Drugs Revenue by Application (2020-2031)
5.2.1 Global Cancer Treatment Drugs Revenue by Application (2020-2025)
5.2.2 Global Cancer Treatment Drugs Revenue by Application (2026-2031)
5.2.3 Global Cancer Treatment Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Cancer Treatment Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Cancer Treatment Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Cancer Treatment Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Company Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Celgene Cancer Treatment Drugs Product Portfolio
6.3.5 Celgene Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Company Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Company Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amgen Cancer Treatment Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Cancer Treatment Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Cancer Treatment Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Company Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Cancer Treatment Drugs Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Company Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Eli Lilly Cancer Treatment Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Company Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AstraZeneca Cancer Treatment Drugs Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Astellas
6.11.1 Astellas Company Information
6.11.2 Astellas Description and Business Overview
6.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Astellas Cancer Treatment Drugs Product Portfolio
6.11.5 Astellas Recent Developments/Updates
6.12 Merck & Co.
6.12.1 Merck & Co. Company Information
6.12.2 Merck & Co. Description and Business Overview
6.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck & Co. Cancer Treatment Drugs Product Portfolio
6.12.5 Merck & Co. Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Company Information
6.13.2 Sanofi Description and Business Overview
6.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sanofi Cancer Treatment Drugs Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Company Information
6.14.2 Bayer Description and Business Overview
6.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bayer Cancer Treatment Drugs Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 Biogen Idec
6.15.1 Biogen Idec Company Information
6.15.2 Biogen Idec Description and Business Overview
6.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Biogen Idec Cancer Treatment Drugs Product Portfolio
6.15.5 Biogen Idec Recent Developments/Updates
6.16 Eisai
6.16.1 Eisai Company Information
6.16.2 Eisai Description and Business Overview
6.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Eisai Cancer Treatment Drugs Product Portfolio
6.16.5 Eisai Recent Developments/Updates
6.17 Teva
6.17.1 Teva Company Information
6.17.2 Teva Description and Business Overview
6.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Teva Cancer Treatment Drugs Product Portfolio
6.17.5 Teva Recent Developments/Updates
6.18 Otsuka
6.18.1 Otsuka Company Information
6.18.2 Otsuka Description and Business Overview
6.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Otsuka Cancer Treatment Drugs Product Portfolio
6.18.5 Otsuka Recent Developments/Updates
6.19 Merck KGaA
6.19.1 Merck KGaA Company Information
6.19.2 Merck KGaA Description and Business Overview
6.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Merck KGaA Cancer Treatment Drugs Product Portfolio
6.19.5 Merck KGaA Recent Developments/Updates
6.20 Ipsen
6.20.1 Ipsen Company Information
6.20.2 Ipsen Description and Business Overview
6.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Ipsen Cancer Treatment Drugs Product Portfolio
6.20.5 Ipsen Recent Developments/Updates
6.21 AbbVie
6.21.1 AbbVie Company Information
6.21.2 AbbVie Description and Business Overview
6.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 AbbVie Cancer Treatment Drugs Product Portfolio
6.21.5 AbbVie Recent Developments/Updates
6.22 Gilead Sciences
6.22.1 Gilead Sciences Company Information
6.22.2 Gilead Sciences Description and Business Overview
6.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Gilead Sciences Cancer Treatment Drugs Product Portfolio
6.22.5 Gilead Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Treatment Drugs Industry Chain Analysis
7.2 Cancer Treatment Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Treatment Drugs Production Mode & Process Analysis
7.4 Cancer Treatment Drugs Sales and Marketing
7.4.1 Cancer Treatment Drugs Sales Channels
7.4.2 Cancer Treatment Drugs Distributors
7.5 Cancer Treatment Drugs Customer Analysis
8 Cancer Treatment Drugs Market Dynamics
8.1 Cancer Treatment Drugs Industry Trends
8.2 Cancer Treatment Drugs Market Drivers
8.3 Cancer Treatment Drugs Market Challenges
8.4 Cancer Treatment Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Novartis
Bristol–Myers Squibb
Amgen Inc
Johnson & Johnson
Pfizer Inc
Takeda
Eli Lilly
Astrazeneca plc
Astellas
Merck
Sanofi
Bayer
Biogen Idec
Eisai Co Ltd
TEVA
Otsuka
Merck KGaA
Ipsen S A
AbbVie
Gilead Sciences
Celgene
List of Tables
 Table 1. Global Cancer Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cancer Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cancer Treatment Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cancer Treatment Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cancer Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cancer Treatment Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cancer Treatment Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cancer Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cancer Treatment Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Cancer Treatment Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Treatment Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cancer Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cancer Treatment Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Cancer Treatment Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Cancer Treatment Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Cancer Treatment Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Cancer Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cancer Treatment Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Cancer Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cancer Treatment Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cancer Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cancer Treatment Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Cancer Treatment Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Cancer Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cancer Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cancer Treatment Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Cancer Treatment Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Cancer Treatment Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Cancer Treatment Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cancer Treatment Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cancer Treatment Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Cancer Treatment Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Cancer Treatment Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Cancer Treatment Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cancer Treatment Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cancer Treatment Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Cancer Treatment Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Roche Cancer Treatment Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Novartis Cancer Treatment Drugs Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Celgene Company Information
 Table 81. Celgene Description and Business Overview
 Table 82. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Celgene Cancer Treatment Drugs Product
 Table 84. Celgene Recent Developments/Updates
 Table 85. Bristol-Myers Squibb Company Information
 Table 86. Bristol-Myers Squibb Description and Business Overview
 Table 87. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Bristol-Myers Squibb Cancer Treatment Drugs Product
 Table 89. Bristol-Myers Squibb Recent Developments/Updates
 Table 90. Amgen Company Information
 Table 91. Amgen Description and Business Overview
 Table 92. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Amgen Cancer Treatment Drugs Product
 Table 94. Amgen Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Cancer Treatment Drugs Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Pfizer Cancer Treatment Drugs Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Takeda Company Information
 Table 106. Takeda Description and Business Overview
 Table 107. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Takeda Cancer Treatment Drugs Product
 Table 109. Takeda Recent Developments/Updates
 Table 110. Eli Lilly Company Information
 Table 111. Eli Lilly Description and Business Overview
 Table 112. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Eli Lilly Cancer Treatment Drugs Product
 Table 114. Eli Lilly Recent Developments/Updates
 Table 115. AstraZeneca Company Information
 Table 116. AstraZeneca Description and Business Overview
 Table 117. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. AstraZeneca Cancer Treatment Drugs Product
 Table 119. AstraZeneca Recent Developments/Updates
 Table 120. Astellas Company Information
 Table 121. Astellas Description and Business Overview
 Table 122. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Astellas Cancer Treatment Drugs Product
 Table 124. Astellas Recent Developments/Updates
 Table 125. Merck & Co. Company Information
 Table 126. Merck & Co. Description and Business Overview
 Table 127. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Merck & Co. Cancer Treatment Drugs Product
 Table 129. Merck & Co. Recent Developments/Updates
 Table 130. Sanofi Company Information
 Table 131. Sanofi Description and Business Overview
 Table 132. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Sanofi Cancer Treatment Drugs Product
 Table 134. Sanofi Recent Developments/Updates
 Table 135. Bayer Company Information
 Table 136. Bayer Description and Business Overview
 Table 137. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Bayer Cancer Treatment Drugs Product
 Table 139. Bayer Recent Developments/Updates
 Table 140. Biogen Idec Company Information
 Table 141. Biogen Idec Description and Business Overview
 Table 142. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Biogen Idec Cancer Treatment Drugs Product
 Table 144. Biogen Idec Recent Developments/Updates
 Table 145. Eisai Company Information
 Table 146. Eisai Description and Business Overview
 Table 147. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Eisai Cancer Treatment Drugs Product
 Table 149. Eisai Recent Developments/Updates
 Table 150. Teva Company Information
 Table 151. Teva Description and Business Overview
 Table 152. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. Teva Cancer Treatment Drugs Product
 Table 154. Teva Recent Developments/Updates
 Table 155. Otsuka Company Information
 Table 156. Otsuka Description and Business Overview
 Table 157. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. Otsuka Cancer Treatment Drugs Product
 Table 159. Otsuka Recent Developments/Updates
 Table 160. Merck KGaA Company Information
 Table 161. Merck KGaA Description and Business Overview
 Table 162. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 163. Merck KGaA Cancer Treatment Drugs Product
 Table 164. Merck KGaA Recent Developments/Updates
 Table 165. Ipsen Company Information
 Table 166. Ipsen Description and Business Overview
 Table 167. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 168. Ipsen Cancer Treatment Drugs Product
 Table 169. Ipsen Recent Developments/Updates
 Table 170. AbbVie Company Information
 Table 171. AbbVie Description and Business Overview
 Table 172. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 173. AbbVie Cancer Treatment Drugs Product
 Table 174. AbbVie Recent Developments/Updates
 Table 175. Gilead Sciences Company Information
 Table 176. Gilead Sciences Description and Business Overview
 Table 177. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 178. Gilead Sciences Cancer Treatment Drugs Product
 Table 179. Gilead Sciences Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Cancer Treatment Drugs Distributors List
 Table 183. Cancer Treatment Drugs Customers List
 Table 184. Cancer Treatment Drugs Market Trends
 Table 185. Cancer Treatment Drugs Market Drivers
 Table 186. Cancer Treatment Drugs Market Challenges
 Table 187. Cancer Treatment Drugs Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cancer Treatment Drugs
 Figure 2. Global Cancer Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Treatment Drugs Market Share by Type: 2024 & 2031
 Figure 4. Chemotherapy Product Picture
 Figure 5. Targeted Therapy Product Picture
 Figure 6. Immunotherapy Product Picture
 Figure 7. Hormonal Therapy (Biologic Therapy) Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Cancer Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Cancer Treatment Drugs Market Share by Application: 2024 & 2031
 Figure 11. Blood Cancer
 Figure 12. Breast Cancer
 Figure 13. Gastrointestinal Cancer
 Figure 14. Prostate Cancer
 Figure 15. Respiratory or Lung Cancer
 Figure 16. Others
 Figure 17. Global Cancer Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Cancer Treatment Drugs Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Cancer Treatment Drugs Sales (2020-2031) & (K Pcs)
 Figure 20. Global Cancer Treatment Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Cancer Treatment Drugs Report Years Considered
 Figure 22. Cancer Treatment Drugs Sales Share by Manufacturers in 2024
 Figure 23. Global Cancer Treatment Drugs Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Cancer Treatment Drugs Players: Market Share by Revenue in Cancer Treatment Drugs in 2024
 Figure 25. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Cancer Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 28. North America Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 32. Europe Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Cancer Treatment Drugs Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Region (2020-2031)
 Figure 40. China Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. China Taiwan Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Cancer Treatment Drugs by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Cancer Treatment Drugs by Type (2020-2031)
 Figure 61. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Cancer Treatment Drugs by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Cancer Treatment Drugs by Application (2020-2031)
 Figure 64. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Cancer Treatment Drugs Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Cancer Immunotherapy Market
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Precision Cancer Imaging System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Z10214
Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Cryosurgical Equipment for Cancer Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39B12765
Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Brachytherapy Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Q18678
Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Gynecological Cancer Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P10282
Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions